PANPHARMA
DEAD

Serial Number

79152852

Owner

PANPHARMA

Attorney

William C. Wright

Filing Date

Apr 16, 2014

Add to watchlist:

No watchlists yet
View on USPTO

PANPHARMA Trademark

Serial Number: 79152852 • Registration: 4915903

PANPHARMA is a trademark filed by PANPHARMA on April 16, 2014. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

PANPHARMA (2 trademarks)

Zone Industrielle du Clairay

Entity Type: 99

Trademark Details

Filing Date

April 16, 2014

Registration Date

March 15, 2016

Published for Opposition

December 29, 2015

Cancellation Date

September 30, 2022

Goods & Services

Food for babies; food supplements for humans and animals; medical plasters, materials for dressings; all-purpose disinfectants; preparations for destroying vermin; fungicides; Pharmaceutical and veterinary preparations for the treatment of allergies, diseases related to the central nervous system, immune system diseases, autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondilitis, obesity, diabetes, dyslipemia, brain diseases, locomotor disorders of the central nervous system, psychiatric disorder, multiple sclerosis, thrombosis and cancer, cardiovascular diseases, respiratory system diseases, digestive system diseases, haematological system and skeletal system diseases, psychiatric disorders, skin and subcutaneous tissue disorders, renal and urinary disorders, bronchial disorders, asthma, sinusitis, flu-like states, feverish aches, growth and mineralization disorders, veinolimphatic insufficiency and disorders, capillary fragility disorders, acute haemorroidal episodes, infectious conditions, travel sickness, healing of wounds and burns, sleep disorders, nausea and vomiting, constipation, diarrheas, intestinal disorders, nervousness, stress, hysteria, fears, anxiety and temporary tiredness, neurotonic conditions, gout, cold, rhinitis, cough, influenzas, rhinopharyngitis, sore throats, tracheitis, laryngitis and bacterial and non-bacterial anginas, hoarseness, and contusions, eczema, cholesterol, degenerations, cutaneous and mucuous disorders, physical and psychic asthenia, menopause, menstruation-related disorders, allergic disorders, gynaecological diseases, rheumatic diseases, urological diseases, gastro-enterological diseases, ophtalmological diseases, dermatological diseases, genital diseases, endocrine diseases, intestinal diseases, blood-related diseases, diseases related to internal medicine, circulatory disorders, muscular disorders, nephropathy, pulmonary embolism, hypertension, atherothrombosis, arrythmia, hearing failure, epilepsy, schizophrenia, neurotic and psychosomatic disorders, hyperplasia, prostate, toxoplasmosis, malaria, malignant and benign tumors, hypercalcemia, hyperuremia, tuberculosis, whooping cough, diphtheria, poliomyelitis, rabies, allergic reactions, metabolic disorder, and control of allergic reactions or metabolic disorders; Pharmaceutical preparations for smoking cessation, pharmaceutical sedatives, tranquilizers, depuratives for the body; sanitary preparations for medical use; Dietetic food and substances for medical or veterinary use, namely, crackers, cakes, soup, meal replacement bars, fruit and vegetable granules adapted for medical use; material for dental fillings and dental impressions; antibiotics, virucides, biocides, bactericides, pharmaceutical and veterinary preparations for the treatment of allergies, diseases related to the central nervous system, immune system diseases, autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondilitis, obesity, diabetes, dyslipemia, brain diseases, locomotor disorders of the central nervous system, break down, multiple sclerosis, thrombosis and cancer, cardiovascular diseases, respiratory system diseases, digestive system diseases, haematological system and skeletal system diseases, psychiatric disorders, skin and subcutaneous tissue disorders, renal and urinary disorders, bronchial disorders, asthma, sinusitis, flu-like states, feverish aches, growth and mineralization disorders, veinolimphatic insufficiency and disorders, capillary fragility disorders, acute haemorroidal episodes, infectious conditions, travel sickness, healing of wounds and burns, sleep disorders, nausea and vomiting, constipation, diarrheas, intestinal disorders, nervousness, stress, hysteria, fears, anxiety and temporary tiredness, neurotonic conditions, gout, cold, rhinitis, cough, influenzas, rhinopharyngitis, sore throats, tracheitis, laryngitis and bacterial and non-bacterial anginas, hoarseness, kicks, lumps and contusions, eczema, cholesterol, degenerations, cutaneous and mucuous disorders, physical and psychic asthenia, menopause, menstruation-related disorders, allergic disorders, gynaecological diseases, rheumatic diseases, urological diseases, gastro-enterological diseases, ophtalmological diseases, dermatological diseases, genital diseases, endocrine diseases, intestinal diseases, blood-related diseases, diseases related to internal medicine, circulatory disorders, muscular disorders, nephropathy, pulmonary embolism, hypertension, atherothrombosis, arrythmia, hearing failure, epilepsy, schizophrenia, neurotic and psychosomatic disorders, hyperplasia, prostate, toxoplasmosis, malaria, malignant and benign tumors, hypercalcemia, hyperuremia, tuberculosis, whooping cough, diphtheria, poliomyelitis, rabies, allergic reactions, metabolic disorder, and control of allergic reactions or metabolic disorders; chemical or pharmaceutical preparations for diagnosis for medical and veterinary purposes, namely, diagnostic preparations for medical and veterinary use; Adjuvants for medical and veterinary purposes, namely for the treatment of allergies, diseases related to the central nervous system, immune system diseases, autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondilitis, obesity, diabetes, dyslipemia, brain diseases, locomotor disorders of the central nervous system, break down, multiple sclerosis, thrombosis and cancer, cardiovascular diseases, respiratory system diseases, digestive system diseases, haematological system and skeletal system diseases, psychiatric disorders, skin and subcutaneous tissue disorders, renal and urinary disorders, bronchial disorders, asthma, sinusitis, flu-like states, feverish aches, growth and mineralization disorders, veinolimphatic insufficiency and disorders, capillary fragility disorders, acute haemorroidal episodes, infectious conditions, travel sickness, healing of wounds and burns, sleep disorders, nausea and vomiting, constipation, diarrheas, intestinal disorders, nervousness, stress, hysteria, fears, anxiety and temporary tiredness, neurotonic conditions, gout, cold, rhinitis, cough, influenzas, rhinopharyngitis, sore throats, tracheitis, laryngitis and bacterial and non-bacterial anginas, hoarseness, kicks, lumps and contusions, eczema, cholesterol, degenerations, cutaneous and mucuous disorders, physical and psychic asthenia, menopause, menstruation-related disorders, allergic disorders, gynaecological diseases, rheumatic diseases, urological diseases, gastro-enterological diseases, ophtalmological diseases, dermatological diseases, genital diseases, endocrine diseases, intestinal diseases, blood-related diseases, diseases related to internal medicine, circulatory disorders, muscular disorders, nephropathy, pulmonary embolism, hypertension, atherothrombosis, arrythmia, hearing failure, epilepsy, schizophrenia, neurotic and psychosomatic disorders, hyperplasia, prostate, toxoplasmosis, malaria, malignant and benign tumors, hypercalcemia, hyperuremia, tuberculosis, whooping cough, diphtheria, poliomyelitis, rabies, allergic reactions, metabolic disorder, and control of allergic reactions or metabolic disorders; chemical or chemical-pharmaceutical products and preparations for medical and veterinary purposes, namely, chemical reagents for medical or veterinary purposes; remedies for human and animal medicine, namely natural remedy preparations for the treatment of allergies, diseases related to the central nervous system, immune system diseases, autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondilitis, obesity, diabetes, dyslipemia, brain diseases, locomotor disorders of the central nervous system, break down, multiple sclerosis, thrombosis and cancer, cardiovascular diseases, respiratory system diseases, digestive system diseases, haematological system and skeletal system diseases, psychiatric disorders, skin and subcutaneous tissue disorders, renal and urinary disorders, bronchial disorders, asthma, sinusitis, flu-like states, feverish aches, growth and mineralization disorders, veinolimphatic insufficiency and disorders, capillary fragility disorders, acute haemorroidal episodes, infectious conditions, travel sickness, healing of wounds and burns, sleep disorders, nausea and vomiting, constipation, diarrheas, intestinal disorders, nervousness, stress, hysteria, fears, anxiety and temporary tiredness, neurotonic conditions, gout, cold, rhinitis, cough, influenzas, rhinopharyngitis, sore throats, tracheitis, laryngitis and bacterial and non-bacterial anginas, hoarseness, kicks, lumps and contusions, eczema, cholesterol, degenerations, cutaneous and mucuous disorders, physical and psychic asthenia, menopause, menstruation-related disorders, allergic disorders, gynaecological diseases, rheumatic diseases, urological diseases, gastro-enterological diseases, ophtalmological diseases, dermatological diseases, genital diseases, endocrine diseases, intestinal diseases, blood-related diseases, diseases related to internal medicine, circulatory disorders, muscular disorders, nephropathy, pulmonary embolism, hypertension, atherothrombosis, arrythmia, hearing failure, epilepsy, schizophrenia, neurotic and psychosomatic disorders, hyperplasia, prostate, toxoplasmosis, malaria, malignant and benign tumors, hypercalcemia, hyperuremia, tuberculosis, whooping cough, diphtheria, poliomyelitis, rabies, allergic reactions, metabolic disorder, and control of allergic reactions or metabolic disorders; antibiotics, antibiotic preparations; hormones for medical purposes, preparations containing hormones for the treatment of allergies, diseases related to the central nervous system, immune system diseases, autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondilitis, obesity, diabetes, dyslipemia, brain diseases, locomotor disorders of the central nervous system, break down, multiple sclerosis, thrombosis and cancer, cardiovascular diseases, respiratory system diseases, digestive system diseases, haematological system and skeletal system diseases, psychiatric disorders, skin and subcutaneous tissue disorders, renal and urinary disorders, bronchial disorders, asthma, sinusitis, flu-like states, feverish aches, growth and mineralization disorders, veinolimphatic insufficiency and disorders, capillary fragility disorders, acute haemorroidal episodes, infectious conditions, travel sickness, healing of wounds and burns, sleep disorders, nausea and vomiting, constipation, diarrheas, intestinal disorders, nervousness, stress, hysteria, fears, anxiety and temporary tiredness, neurotonic conditions, gout, cold, rhinitis, cough, influenzas, rhinopharyngitis, sore throats, tracheitis, laryngitis and bacterial and non-bacterial anginas, hoarseness, kicks, lumps and contusions, eczema, cholesterol, degenerations, cutaneous and mucuous disorders, physical and psychic asthenia, menopause, menstruation-related disorders, allergic disorders, gynaecological diseases, rheumatic diseases, urological diseases, gastro-enterological diseases, ophtalmological diseases, dermatological diseases, genital diseases, endocrine diseases, intestinal diseases, blood-related diseases, diseases related to internal medicine, circulatory disorders, muscular disorders, nephropathy, pulmonary embolism, hypertension, atherothrombosis, arrythmia, hearing failure, epilepsy, schizophrenia, neurotic and psychosomatic disorders, hyperplasia, prostate, toxoplasmosis, malaria, malignant and benign tumors, hypercalcemia, hyperuremia, tuberculosis, whooping cough, diphtheria, poliomyelitis, rabies, allergic reactions, metabolic disorder, and control of allergic reactions or metabolic disorders; injectable pharmaceutical preparations for the treatment of allergies, diseases related to the central nervous system, immune system diseases, autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondilitis, obesity, diabetes, dyslipemia, brain diseases, locomotor disorders of the central nervous system, break down, multiple sclerosis, thrombosis and cancer, cardiovascular diseases, respiratory system diseases, digestive system diseases, haematological system and skeletal system diseases, psychiatric disorders, skin and subcutaneous tissue disorders, renal and urinary disorders, bronchial disorders, asthma, sinusitis, flu-like states, feverish aches, growth and mineralization disorders, veinolimphatic insufficiency and disorders, capillary fragility disorders, acute haemorroidal episodes, infectious conditions, travel sickness, healing of wounds and burns, sleep disorders, nausea and vomiting, constipation, diarrheas, intestinal disorders, nervousness, stress, hysteria, fears, anxiety and temporary tiredness, neurotonic conditions, gout, cold, rhinitis, cough, influenzas, rhinopharyngitis, sore throats, tracheitis, laryngitis and bacterial and non-bacterial anginas, hoarseness, kicks, lumps and contusions, eczema, cholesterol, degenerations, cutaneous and mucuous disorders, physical and psychic asthenia, menopause, menstruation-related disorders, allergic disorders, gynaecological diseases, rheumatic diseases, urological diseases, gastro-enterological diseases, ophtalmological diseases, dermatological diseases, genital diseases, endocrine diseases, intestinal diseases, blood-related diseases, diseases related to internal medicine, circulatory disorders, muscular disorders, nephropathy, pulmonary embolism, hypertension, atherothrombosis, arrythmia, hearing failure, epilepsy, schizophrenia, neurotic and psychosomatic disorders, hyperplasia, prostate, toxoplasmosis, malaria, malignant and benign tumors, hypercalcemia, hyperuremia, tuberculosis, whooping cough, diphtheria, poliomyelitis, rabies, allergic reactions, metabolic disorder, and control of allergic reactions or metabolic disorders; tapes and strips for medical and veterinary diagnostic purposes, namely, medical diagnostic test strips for use in the field of gynecology and urology; self-diagnosis tapes and strips for medical purposes for use in the field of gynecology and urology; articles for medical and surgical dressings namely surgical tapes, surgical adhesives, surgical and medical dressings; additives for vaccines, namely, vaccine stablilizers; oral vaccine preparations; vaccines against flu; vaccines against pneumococcal infections; vaccines for human use; vaccines for veterinary use; medicated preparations for skin care and treatment; pharmaceutical preparations for skin care for animals; sanitizing preparations for hospital use; disinfectants for medical apparatus and instruments; disinfectants for medical use; disinfectants for hand wash for medical purposes; medicines for the treatment of allergies, diseases related to the central nervous system, immune system diseases, autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondilitis, obesity, diabetes, dyslipemia, brain diseases, locomotor disorders of the central nervous system, break down, multiple sclerosis, thrombosis and cancer, cardiovascular diseases, respiratory system diseases, digestive system diseases, haematological system and skeletal system diseases, psychiatric disorders, skin and subcutaneous tissue disorders, renal and urinary disorders, bronchial disorders, asthma, sinusitis, flu-like states, feverish aches, growth and mineralization disorders, veinolimphatic insufficiency and disorders, capillary fragility disorders, acute haemorroidal episodes, infectious conditions, travel sickness, healing of wounds and burns, sleep disorders, nausea and vomiting, constipation, diarrheas, intestinal disorders, nervousness, stress, hysteria, fears, anxiety and temporary tiredness, neurotonic conditions, gout, cold, rhinitis, cough, influenzas, rhinopharyngitis, sore throats, tracheitis, laryngitis and bacterial and non-bacterial anginas, hoarseness, kicks, lumps and contusions, eczema, cholesterol, degenerations, cutaneous and mucuous disorders, physical and psychic asthenia, menopause, menstruation-related disorders, allergic disorders, gynaecological diseases, rheumatic diseases, urological diseases, gastro-enterological diseases, ophtalmological diseases, dermatological diseases, genital diseases, endocrine diseases, intestinal diseases, blood-related diseases, diseases related to internal medicine, circulatory disorders, muscular disorders, nephropathy, pulmonary embolism, hypertension, atherothrombosis, arrythmia, hearing failure, epilepsy, schizophrenia, neurotic and psychosomatic disorders, hyperplasia, prostate, toxoplasmosis, malaria, malignant and benign tumors, hypercalcemia, hyperuremia, tuberculosis, whooping cough, diphtheria, poliomyelitis, rabies, allergic reactions, metabolic disorder, and control of allergic reactions or metabolic disorders; tonics medicines for the treatment of allergies, diseases related to the central nervous system, immune system diseases, autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondilitis, obesity, diabetes, dyslipemia, brain diseases, locomotor disorders of the central nervous system, break down, multiple sclerosis, thrombosis and cancer, cardiovascular diseases, respiratory system diseases, digestive system diseases, haematological system and skeletal system diseases, psychiatric disorders, skin and subcutaneous tissue disorders, renal and urinary disorders, bronchial disorders, asthma, sinusitis, flu-like states, feverish aches, growth and mineralization disorders, veinolimphatic insufficiency and disorders, capillary fragility disorders, acute haemorroidal episodes, infectious conditions, travel sickness, healing of wounds and burns, sleep disorders, nausea and vomiting, constipation, diarrheas, intestinal disorders, nervousness, stress, hysteria, fears, anxiety and temporary tiredness, neurotonic conditions, gout, cold, rhinitis, cough, influenzas, rhinopharyngitis, sore throats, tracheitis, laryngitis and bacterial and non-bacterial anginas, hoarseness, kicks, lumps and contusions, eczema, cholesterol, degenerations, cutaneous and mucuous disorders, physical and psychic asthenia, menopause, menstruation-related disorders, allergic disorders, gynaecological diseases, rheumatic diseases, urological diseases, gastro-enterological diseases, ophtalmological diseases, dermatological diseases, genital diseases, endocrine diseases, intestinal diseases, blood-related diseases, diseases related to internal medicine, circulatory disorders, muscular disorders, nephropathy, pulmonary embolism, hypertension, atherothrombosis, arrythmia, hearing failure, epilepsy, schizophrenia, neurotic and psychosomatic disorders, hyperplasia, prostate, toxoplasmosis, malaria, malignant and benign tumors, hypercalcemia, hyperuremia, tuberculosis, whooping cough, diphtheria, poliomyelitis, rabies, allergic reactions, metabolic disorder, and control of allergic reactions or metabolic disorders; drug delivery agents in the form of dissolvable films, coatings for tablets that facilitate the delivery of nutritional supplements; therapeutic drugs and agents, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; medicines for veterinary use, namely vaccines for use on domestic animals and livestock for veterinary purposes; medicines for veterinary use, namely, antiparasitic collars for animals, antiparasitic preparations, analgesics, general anesthetics, antiseptics, anti-uric preparations; chemical reagents for diagnosis for medical, veterinary and therapeutic purposes

Filing History

GENERIC MADRID TRANSACTION SENT TO IB
Mar 18, 2025 XXSS
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Mar 18, 2025 INNA
GENERIC MADRID TRANSACTION CREATED
Mar 18, 2025 XXCR
INTERNATIONAL REGISTRATION RENEWED
Feb 16, 2024 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
Nov 20, 2023 NREP
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
May 30, 2023 INTR
CANCELLED SECTION 71
Sep 30, 2022 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 15, 2021 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Mar 6, 2021 NREP
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Mar 6, 2021 CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jun 14, 2017 CORN
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 28, 2017 FINO
CORRECTION TRANSACTION RECEIVED FROM IB
Mar 10, 2017 CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
Mar 10, 2017 CRCV
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 18, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 17, 2016 FICS
FINAL DISPOSITION PROCESSED
Jun 17, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 15, 2016 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 25, 2016 OPNX
REGISTERED-PRINCIPAL REGISTER
Mar 15, 2016 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 9, 2016 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 9, 2016 OPNR
NOTIFICATION PROCESSED BY IB
Jan 4, 2016 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 29, 2015 NPUB
PUBLISHED FOR OPPOSITION
Dec 29, 2015 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 9, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 9, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 9, 2015 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 20, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 12, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 12, 2015 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 12, 2015 ERFR
FINAL REFUSAL MAILED
Jun 29, 2015 CNFR
FINAL REFUSAL WRITTEN
Jun 28, 2015 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 15, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 15, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 15, 2015 TROA
REFUSAL PROCESSED BY IB
Jan 8, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 22, 2014 RFCS
REFUSAL PROCESSED BY MPU
Dec 22, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 20, 2014 RFCR
NON-FINAL ACTION WRITTEN
Dec 19, 2014 CNRT
APPLICATION FILING RECEIPT MAILED
Dec 17, 2014 MAFR
ASSIGNED TO EXAMINER
Dec 13, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 13, 2014 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 14, 2014 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 9, 2014 REPR